XML 25 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net income $ 12,107 $ 10,835
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 101,781 103,111
Amortization of deferred financing costs 1,480 1,332
Amortization of debt discount/(premium), net (788) 351
Amortization of stock compensation costs 4,462 5,135
Straight-line rent income (4,416) (6,425)
Amortization of acquired above (below) market leases, net (2,617) (3,494)
Ground rent expense 729 737
Provision for doubtful accounts 345 (24)
Net gain on real estate venture transactions 0 (1,535)
Net gain on sale of interests in real estate (2,787) (1,251)
Loss from Real Estate Ventures, net of distributions 4,092 3,857
Income tax provision (benefit) (226) 46
Changes in assets and liabilities:    
Accounts receivable (4,349) (665)
Other assets (3,315) (7,714)
Accounts payable and accrued expenses (4,215) (12,496)
Deferred income, gains and rent (5,418) (5,033)
Other liabilities 3,455 (1,311)
Net cash provided by operating activities 100,320 85,456
Cash flows from investing activities:    
Acquisition of properties (11,432) 0
Proceeds from the sale of properties 21,250 5,523
Proceeds from real estate venture sales 0 259
Proceeds from repayment of mortgage notes receivable 0 3,341
Capital expenditures for tenant improvements (27,834) (36,046)
Capital expenditures for redevelopments (14,686) (18,436)
Capital expenditures for developments (33,566) (39,155)
Advances for the purchase of tenant assets, net of repayments 1,563 (627)
Investment in unconsolidated Real Estate Ventures (199) (182)
Deposits for real estate 0 2,053
Capital distributions from Real Estate Ventures 3,575 33,817
Leasing costs paid (13,998) (9,440)
Net cash used in investing activities (75,327) (58,893)
Cash flows from financing activities:    
Repayments of mortgage notes payable (3,909) (3,761)
Proceeds from credit facility borrowings 132,500 260,500
Repayments of credit facility borrowings (71,500) (189,500)
Proceeds from the exercise of stock options 47 800
Shares used for employee taxes upon vesting of share awards (1,346) (1,554)
Partner contributions to consolidated real estate venture 0 25
Repurchase and retirement of common shares (60,000) (17,282)
Distributions paid to shareholders (66,107) (66,649)
Distributions to noncontrolling interest (374) (373)
Net cash used in financing activities (70,689) (17,794)
Increase/(Decrease) in cash and cash equivalents and restricted cash (45,696) 8,769
Cash and cash equivalents and restricted cash at beginning of year 91,170 23,211
Cash and cash equivalents and restricted cash at end of period 45,474 31,980
Reconciliation of cash and cash equivalents and restricted cash:    
Cash and cash equivalents, beginning of period 90,499 22,842
Restricted cash, beginning of period 671 369
Cash and cash equivalents and restricted cash at beginning of year 91,170 23,211
Cash and cash equivalents, end of period 44,819 31,573
Restricted cash, end of period 655 407
Cash and cash equivalents and restricted cash at end of period 45,474 31,980
Supplemental disclosure:    
Cash paid for interest, net of capitalized interest during the six months ended June 30, 2020 and 2019 of $2,341 and $1,465, respectively 42,994 41,842
Cash paid for income taxes 483 938
Supplemental disclosure of non-cash activity:    
Dividends and distributions declared but not paid 32,747 34,113
Change in investment in real estate ventures as a result of dispositions 0 1,276
Change in capital expenditures financed through accounts payable at period end 5,995 (15,351)
Change in capital expenditures financed through retention payable at period end 222 (3,643)
BRANDYWINE OPERATING PARTNERSHIP, L.P.    
Cash flows from operating activities:    
Net income 12,107 10,835
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 101,781 103,111
Amortization of deferred financing costs 1,480 1,332
Amortization of debt discount/(premium), net (788) 351
Amortization of stock compensation costs 4,462 5,135
Straight-line rent income (4,416) (6,425)
Amortization of acquired above (below) market leases, net (2,617) (3,494)
Ground rent expense 729 737
Provision for doubtful accounts 345 (24)
Net gain on real estate venture transactions 0 (1,535)
Net gain on sale of interests in real estate (2,787) (1,251)
Loss from Real Estate Ventures, net of distributions 4,092 3,857
Income tax provision (benefit) (226) 46
Changes in assets and liabilities:    
Accounts receivable (4,349) (665)
Other assets (3,315) (7,714)
Accounts payable and accrued expenses (4,215) (12,496)
Deferred income, gains and rent (5,418) (5,033)
Other liabilities 3,455 (1,311)
Net cash provided by operating activities 100,320 85,456
Cash flows from investing activities:    
Acquisition of properties (11,432) 0
Proceeds from the sale of properties 21,250 5,523
Proceeds from real estate venture sales 0 259
Proceeds from repayment of mortgage notes receivable 0 3,341
Capital expenditures for tenant improvements (27,834) (36,046)
Capital expenditures for redevelopments (14,686) (18,436)
Capital expenditures for developments (33,566) (39,155)
Advances for the purchase of tenant assets, net of repayments 1,563 (627)
Investment in unconsolidated Real Estate Ventures (199) (182)
Deposits for real estate 0 2,053
Capital distributions from Real Estate Ventures 3,575 33,817
Leasing costs paid (13,998) (9,440)
Net cash used in investing activities (75,327) (58,893)
Cash flows from financing activities:    
Repayments of mortgage notes payable (3,909) (3,761)
Proceeds from credit facility borrowings 132,500 260,500
Repayments of credit facility borrowings (71,500) (189,500)
Proceeds from the exercise of stock options 47 800
Shares used for employee taxes upon vesting of share awards (1,346) (1,554)
Partner contributions to consolidated real estate venture 0 25
Repurchase and retirement of common shares (60,000) (17,282)
Distributions paid to shareholders (66,481) (67,022)
Net cash used in financing activities (70,689) (17,794)
Increase/(Decrease) in cash and cash equivalents and restricted cash (45,696) 8,769
Cash and cash equivalents and restricted cash at beginning of year 91,170 23,211
Cash and cash equivalents and restricted cash at end of period 45,474 31,980
Reconciliation of cash and cash equivalents and restricted cash:    
Cash and cash equivalents, beginning of period 90,499 22,842
Restricted cash, beginning of period 671 369
Cash and cash equivalents and restricted cash at beginning of year 91,170 23,211
Cash and cash equivalents, end of period 44,819 31,573
Restricted cash, end of period 655 407
Cash and cash equivalents and restricted cash at end of period 45,474 31,980
Supplemental disclosure:    
Cash paid for interest, net of capitalized interest during the six months ended June 30, 2020 and 2019 of $2,341 and $1,465, respectively 42,994 41,842
Cash paid for income taxes 483 938
Supplemental disclosure of non-cash activity:    
Dividends and distributions declared but not paid 32,747 34,113
Change in investment in real estate ventures as a result of dispositions 0 1,276
Change in capital expenditures financed through accounts payable at period end 5,995 (15,351)
Change in capital expenditures financed through retention payable at period end $ 222 $ (3,643)